Analysts are split on US Bancorp, but 12 of 26 analysts rate it hold.
You know, I've been discriminated against, but I'm not going to let it hold me down.
Analysts are split on Camden Property, but six of 14 analysts rate it hold.
Analysts are split on Apartment Investment And Management, but four of 12 analysts rate it hold.
FORBES: Earnings Preview: Apartment Investment And Management - Forbes
Analysts are split on Mead Johnson, but five of 10 analysts rate it hold.
Analysts generally think investors should stand pat on Pepco, with analysts unanimously rating it hold.
Analysts are split on Health Care REIT, but eight of 18 analysts rate it hold.
Analysts are split on Analog Devices, but 11 of 22 analysts rate it hold.
Analysts are split on Biogen Idec, but 11 of 22 analysts rate it hold.
Analysts are split on Morgan Stanley, but eight of 22 analysts rate it hold.
Analysts are split on Digital Realty Trust, but seven of 16 analysts rate it hold.
Analysts are split on AllianceBernstein Holding, but two of six analysts rate it hold.
Analysts are split on Edwards Lifesciences, but seven of 18 analysts rate it hold.
Most analysts think investors should stand pat on GlaxoSmithKline, with seven of 10 analysts rating it hold.
Most analysts think investors should stand pat on NYSE, with eight of 13 analysts rating it hold.
Analysts generally think investors should stand pat on McKesson, with five of 10 analysts rating it hold.
Analysts generally think investors should stand pat on AIG, with nine of 18 analysts rating it hold.
Analysts generally think investors should stand pat on Masco, with seven of 14 analysts rating it hold.
Analysts generally think investors should stand pat on Expedia, with 10 of 16 analysts rating it hold.
Most analysts think investors should stand pat on PACCAR, with nine of 16 analysts rating it hold.
Analysts generally think investors should stand pat on FirstEnergy, with 11 of 14 analysts rating it hold.
Analysts generally think investors should stand pat on Zions, with 12 of 19 analysts rating it hold.
Most analysts think investors should stand pat on Progressive, with nine of 18 analysts rating it hold.
Analysts generally think investors should stand pat on Campbell, with 11 of 15 analysts rating it hold.
Analysts generally think investors should stand pat on Ameren, with eight of 10 analysts rating it hold.
Most analysts think investors should stand pat on Yelp, with eight of 13 analysts rating it hold.
Most analysts think investors should stand pat on Amgen, with 12 of 23 analysts rating it hold.
Analysts generally think investors should stand pat on Goldman, with 12 of 20 analysts rating it hold.
Most analysts think investors should stand pat on Avery, with three of five analysts rating it hold.
Most analysts think investors should stand pat on SYSCO, with seven of 10 analysts rating it hold.
应用推荐